Cover Image
市場調查報告書

食道疾病:全球臨床實驗趨勢

Esophageal Diseases Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 332928
出版日期 內容資訊 英文 103 Pages
訂單完成後即時交付
價格
Back to Top
食道疾病:全球臨床實驗趨勢 Esophageal Diseases Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月30日 內容資訊: 英文 103 Pages
簡介

本報告提供食道疾病相關臨床研究的最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗者採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 食道疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上食道疾病的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上食道疾病的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

食道疾病治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • AstraZeneca PLC
    • 武田藥品工業
    • Eisai
    • Johnson & Johnson
    • Pfizer Inc.
    • Indivior PLC
    • Novartis AG
    • Shire Plc
    • Yuhan Corporation
    • Dr. Reddy's Laboratories Limited
  • 有代表性的研究機關·醫院臨床實驗概要
    • Mayo Clinic
    • 島根大學
    • Academic Medical Center
    • The University of Utah
    • Zhongshan Hospital
    • Chinese University of Hong Kong
    • Cincinnati Children's Hospital Medical Center
    • Department of Health, UK
    • 兵庫醫科大學
    • 順天堂大學醫學系

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2675CTIDB

GlobalData's clinical trial report, "Esophageal Diseases Global Clinical Trials Review, H1, 2015" provides data on the Esophageal Diseases clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophageal Diseases. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Esophageal Diseases. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Esophageal Diseases
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Esophageal Diseases
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Esophageal Diseases Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Indivior PLC
      • Clinical Trial Overview of Indivior PLC
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • Yuhan Corporation
      • Clinical Trial Overview of Yuhan Corporation
      • Dr. Reddy's Laboratories Limited
      • Clinical Trial Overview of Dr. Reddy's Laboratories Limited
    • Clinical Trial Overview of Top Institutes / Government
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Shimane University
      • Clinical Trial Overview of Shimane University
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • The University of Utah
      • Clinical Trial Overview of The University of Utah
      • Zhongshan Hospital
      • Clinical Trial Overview of Zhongshan Hospital
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Cincinnati Children's Hospital Medical Center
      • Clinical Trial Overview of Cincinnati Children's Hospital Medical Center
      • Department of Health, UK
      • Clinical Trial Overview of Department of Health, UK
      • Hyogo College Of Medicine
      • Clinical Trial Overview of Hyogo College Of Medicine
      • Juntendo University School of Medicine
      • Clinical Trial Overview of Juntendo University School of Medicine
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Esophageal Diseases Therapeutics, Global, Clinical Trials by Region, 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Esophageal Diseases Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Esophageal Diseases Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Esophageal Diseases Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Esophageal Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Indivior PLC, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Yuhan Corporation, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhongshan Hospital, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015*

List of Figures

  • Esophageal Diseases Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Esophageal Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Esophageal Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Esophageal Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Esophageal Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Esophageal Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Esophageal Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top